Gene · 9780
Papers3,250
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 3,250
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mechanosensitive Ion Channel PIEZO1 Suppresses BMP2-Induced Ossification of the Annulus Fibrosus Cells. | JOR Spine | 2026 | 41783545 | PubTator, text mining | PubMed |
| Targeted knockdown of Piezo1 in synovial macrophages attenuates osteoarthritis development. | J Orthop Translat | 2026 | 41782854 | PubTator, text mining | PubMed |
| Piezo1 Channel Mediates Mechanically Programmable Drug Delivery to Potentiate Intravesical Chemotherapy. | Adv Sci (Weinh) | 2026 | 41782384 | PubTator, text mining | PubMed |
| The molecular basis of force selectivity by PIEZO2. | Nature | 2026 | 41781615 | PubTator, text mining | PubMed |
| Compressive stress-driven Piezo1 activation and Rho-ROCK mechanotransduction promote tumor progression via epigenetic mechanical memory. | Sci Adv | 2026 | 41779857 | PubTator, text mining | PubMed |
| From mechanosensing to immune regulation: mechanisms of acupuncture signal initiation and amplification mediated by macrophages. | Front Immunol | 2026 | 41777879 | PubTator, text mining | PubMed |
| Challenges and advances in drug resistance and tolerance in cancer. | J Exp Clin Cancer Res | 2026 | 41776655 | PubTator, text mining | PubMed |
| Piezo1-dependent activation of stromal cells ignites muscle inflammation in exercise and injury and is associated with inflammaging. | Nat Immunol | 2026 | 41775886 | PubTator, text mining | PubMed |
| Velocity sensitivity of mechanotransduction in the afferent terminal underlies vibration detection in the Pacinian corpuscle. | Nat Commun | 2026 | 41775685 | PubTator, text mining | PubMed |
| Piezo1-PHLPP2-PI3K/AKT axis represents a novel signalling cascade driving EMT and local invasion in colorectal cancer. | Pathol Res Pract | 2026 | 41775212 | PubTator, text mining | PubMed |
| Etiology, diagnosis and treatment of lumbar disc degeneration: a focus on the mechanism of action of Piezo1 and research perspectives. | Front Cell Dev Biol | 2026 | 41769000 | PubTator, text mining | PubMed |
| Multiomics Integration Reveals Yu-Xue-Bi Tablets Attenuate Rheumatoid Arthritis via Metabolic Reprogramming-Mediated Piezo1 Suppression. | ACS Omega | 2026 | 41768742 | PubTator, text mining | PubMed |
| Nested ecosystems theory for conceptualizing brain tumors. | Dis Model Mech | 2026 | 41757579 | PubTator, text mining | PubMed |
| Intracellular Mechanosensation in Intestinal Smooth Muscle: Piezo1 Complexes Amplify Signaling Beyond the Surface. | bioRxiv | 2026 | 41757082 | PubTator, text mining | PubMed |
| Piezo2 tension sensitivity and its modulation by alternative splicing. | bioRxiv | 2026 | 41756966 | PubTator, text mining | PubMed |
| Blood Mechanical Intelligence: From Force Sensing to Precision Mechanomedicine. | Research (Wash D C) | 2026 | 41756726 | PubTator, text mining | PubMed |
| Matching heterogeneous cohorts by projected principal components reveals two novel Alzheimer's disease-associated genes in the Hispanic population. | Alzheimers Dement | 2026 | 41755704 | PubTator, text mining | PubMed |
| Biological and Biophysical Characterization of Hybrid PLCL Nanofibers Incorporating Stem Cell-Derived Secretome. | Polymers (Basel) | 2026 | 41754720 | PubTator, text mining | PubMed |
| Integration of Fibroblast-Populated Collagen Lattices and Perfusable Micro-Physiological Systems: A Mechanobiologically Unified Framework for Living Devices. | Micromachines (Basel) | 2026 | 41753826 | PubTator, text mining | PubMed |
| The Dynamics of Neuroinflammation in Traumatic Brain Injury: Molecular Markers Useful for Establishing the Post-Traumatic Interval in Forensic Practice. | Int J Mol Sci | 2026 | 41752185 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9780/papers?page=16